Effectiveness of a pharmacist-led drug counseling on enhancing antihypertensive adherence and blood pressure control: A randomized controlled trial

Journal of Clinical Pharmacology

Volumn 53, Issue 7, 2013, Pages 753-761

  Wong, Martin C S ^a,e   Liu, Kirin Q L ^a   Wang, Harry H X ^a   Lee, Catherine L S ^a   Kwan, Mandy W M ^a   Lee, Ken W S ^b   Cheung, Yu ^c   Lee, Gabrielle K Y ^a   Morisky, Donald E ^d   Griffiths, Sian M ^a  

^a and Hong Kong Branch of CAS Center for Excellence in Animal Evolution and Genetics   (Hong Kong)

^b Society of Hospital Pharmacists of Hong Kong   (Hong Kong)

^c HOSPITAL AUTHORITY   (Hong Kong)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Adherence; Antihypertensive; Clinical practice; Medication counseling; Pharmacist intervention

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ADULT; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE REGULATION; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DRUG WITHDRAWAL; EDUCATIONAL STATUS; EMPLOYMENT STATUS; FEMALE; FOLLOW UP; GENERAL PRACTICE; HONG KONG; HUMAN; HYPERTENSION; INCOME; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PATIENT COUNSELING; PHARMACIST; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SYSTOLIC BLOOD PRESSURE;

ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; COUNSELING; FAMILY PRACTICE; FEMALE; HONG KONG; HUMANS; HYPERTENSION; MALE; MEDICATION ADHERENCE; MIDDLE AGED; PHARMACISTS;

EID: 84880309891     PISSN: 00912700     EISSN: 15524604     Source Type: Journal    
DOI: 10.1002/jcph.101     Document Type: Article

References (25)

1. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J, Global burden of hypertension: analysis of worldwide data. Lancet. 2005;365:217-223.
2. World Health Report 2002. Reducing Risks. Promoting Healthy Life. Geneva, Switzerland: World Health Organization; 2002.
3. HDFP Cooperative Group. Five-year findings of the hypertension detection and follow-up program. I. Reduction in mortality in persons with high blood pressure, including mild hypertension. JAMA. 1979;242:2562-71.
4. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. JAMA. 1991;265:3255-3264.
5. Wolf-Maier K, Cooper RS, Kramer H, et al. Hypertension treatment and control in five European countries, Canada, and the United States. Hypertension. 2004;43:10-17.
6. Whelton PK, He J, Muntner P. Prevalence, awareness, treatment and control of hypertension in North America, North Africa, and Asia. J Hum Hypertens. 2004;18:545-551.
7. Stephenson, J. Noncompliance may cause half of antihypertensive drug "failures". JAMA. 1999;282:313-314.
8. Burnier M, Schneider MP, Chiolero A, Stubi CL, Brunner HR. Electronic compliance monitoring in resistant hypertension: the basis for rational therapeutic decisions. J Hypertens. 2001;19:335-341.
9. van Wijk BLG, Shrank WH, Klungel OH, Schneeweiss S, Brookhart MA, Avorn J. A cross-national study of the persistence of antihypertensive medication use in the elderly. J Hypertens. 2008;26:145-153.
10. Setaro JF, Black HR. Refractory hypertension. N Engl J Med. 1992;327:543-547.
11. Osterberg L, Blaschke T. Drug therapy: adherence to medication. N Engl J Med. 2005;353:487-497.
12. Rodgers PT, Ruffin DM. Medication nonadherence: part II -a pilot study in patients with congestive heart failure. Manag Care Interface. 1998;11:67-69.
13. Van Wijk BL, Klungel OH, Heerdink ER, de Boer A. Initial noncompliance with antihypertensive monotherapy is followed by complete discontinuation of antihypertensive therapy. Pharmacoepidemiol Drug Saf. 2006;15:587-593.
14. Smith DH, Kramer JM, Perrin N, et al. A randomized trial of direct-to-patient communication to enhance adherence to bblocker therapy following myocardial infarction. Arch Intern Med. 2008;168:477-483.
15. Rosen MI, Rigsby MO, Salahi JT, Ryan CE, Cramer JA. Electronic monitoring and counseling to improve medication adherence. Behav Res Ther 2004;42:409-422.
16. Friedman RH, Kazis LE, Jette A, et al. Atelecommunications system for monitoring and counseling patients with hypertension: impact on medication adherence and blood pressure control. Am J Hypertens. 1996;9:285-292.
17. Faulkner MA, Wadibia EC, Lucas BD, Hilleman DE. Impact of pharmacy counseling on compliance and effectiveness of combination lipid-lowering therapy in patients undergoing coronary artery revascularization: a randomized, controlled trial. Pharmacotherapy. 2000;20:410-416.
18. Morisky DE, DeMuth NM, Field-Fass M, Green LW, Levine DM. Evaluation of family health education to build social support for long-term control of high blood pressure. Health Educ Q. 1985;12:35-50.
19. Blenkinsopp A, Phelan M, Bourne J, Dakhil N. Extended adherence support by community pharmacists for patients with hypertension: a randomised controlled trial. Int J Pharm Pract. 2000;8:165-175.
20. Lee JK, Grace KA, Taylor AJ. Effect of a pharmacy care program on medication adherence and persistence, blood pressure, and lowdensity lipoprotein cholesterol.: a randomized controlled trial. JAMA. 2006;296:2563-2571.
21. Population census 2006. Hong Kong Special Administrative Region, China. Available at http://www.bycensus2006.gov.hk/en/index.htm (accessed on February 05, 2013).
22. Krousel-Wood MA, Muntner P, Islam T, Morisky DE, Webber LS. Barriers to and determinants of medication adherence in hypertension management: perspective of the cohort study of medication adherence among older adults. Med Clin N Am 2009;93:753-769.
23. Morisky DE, Ang A, Krousel-Wood M, Ward HJ. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens 2008;10:348-354.
24. Krousel-Wood M, Islam T, Webber LS, Re RN, Morisky DE, Muntner P. New medication adherence scale versus pharmacy fill rates in seniors with hypertension. Am J Manag Care 2009;15:59-66.
25. Zhang SY, Bai LQ, Tan HZ, Yang HL, Application of the morisky medication adherence scale on pulmonary tuberculosis patients. Chin J Antitubers. 2010;32:527-530.